EA202190844A1 - METHODS FOR TREATMENT OF MYELOPROLIFERATIVE DISORDERS - Google Patents

METHODS FOR TREATMENT OF MYELOPROLIFERATIVE DISORDERS

Info

Publication number
EA202190844A1
EA202190844A1 EA202190844A EA202190844A EA202190844A1 EA 202190844 A1 EA202190844 A1 EA 202190844A1 EA 202190844 A EA202190844 A EA 202190844A EA 202190844 A EA202190844 A EA 202190844A EA 202190844 A1 EA202190844 A1 EA 202190844A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
treatment
myeloproliferative disorders
myeloproliferative
disorders
Prior art date
Application number
EA202190844A
Other languages
Russian (ru)
Inventor
Тимара Берри
Джон ХУД
Катриона Джеймисон
Кертис Л. Скрибнер
Original Assignee
Импэкт Байомедисинс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Импэкт Байомедисинс, Инк. filed Critical Импэкт Байомедисинс, Инк.
Priority claimed from PCT/US2019/052608 external-priority patent/WO2020068755A1/en
Publication of EA202190844A1 publication Critical patent/EA202190844A1/en

Links

Abstract

В настоящем изобретении предложены способы уменьшения дефицита тиамина.The present invention provides methods for reducing thiamine deficiency.

EA202190844A 2018-12-20 2019-09-24 METHODS FOR TREATMENT OF MYELOPROLIFERATIVE DISORDERS EA202190844A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862783076P 2018-12-20 2018-12-20
PCT/US2019/052608 WO2020068755A1 (en) 2018-09-25 2019-09-24 Methods of treating myeloproliferative disorders

Publications (1)

Publication Number Publication Date
EA202190844A1 true EA202190844A1 (en) 2021-07-05

Family

ID=77443290

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202190844A EA202190844A1 (en) 2018-12-20 2019-09-24 METHODS FOR TREATMENT OF MYELOPROLIFERATIVE DISORDERS

Country Status (1)

Country Link
EA (1) EA202190844A1 (en)

Similar Documents

Publication Publication Date Title
MX2021010193A (en) Azepino-indoles and other heterocycles for treating brain disorders.
MX2023004593A (en) Tyk2 inhibitors and uses thereof.
CY1121359T1 (en) HETEROYARLY COMPOUNDS FOR MOTION SUSPENSION
GEP20247593B (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
CL2022000448A1 (en) Autoinjector (divisional application no. 201903061)
MX2019013072A (en) Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies.
MX2020003425A (en) Treatment of inflammatory disorders.
MX2019003623A (en) Compositions and methods for treating ophthalmic conditions.
MX2018008105A (en) Metalloenzyme inhibitor compounds.
MX2018008815A (en) Bruton's tyrosine kinase inhibitors.
MX2021003450A (en) Methods of treating myeloproliferative disorders.
EA201890185A1 (en) METHODS OF TREATMENT OF DISEASES MEDIATED BY GEPSID
MX2018016057A (en) Compositions and methods for treating cardiovascular disease.
PH12018500887A1 (en) Anti-htra1 antibodies and methods of use thereof
MX2019011116A (en) Bruton's tyrosine kinase inhibitors.
EA201792604A1 (en) AUTOTAXIN INHIBITORS AND THEIR APPLICATIONS
MX2018009325A (en) Compounds and methods of treating rna-mediated diseases.
MX2020004666A (en) Compositions and methods for the treatment of eye disorders.
PH12019500751A1 (en) Carbamoyl phenylalaninol compounds and uses thereof
EA201990400A1 (en) COMPOUNDS AND COMPOSITIONS AND THEIR APPLICATION
MX2018006700A (en) Aza-benzimidazole inhibitors of pad4.
MX2021005394A (en) Co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies.
PH12020551336A1 (en) Anti-klk5 antibodies and methods of use
EA202191086A1 (en) COMBINED MELANOMA THERAPY
EA201790893A1 (en) METHODS OF TREATMENT OF OPHTHALMOLOGICAL DISORDERS